Nkarta, Inc.

Contributing Author

Recent Articles by Nkarta, Inc.

Apr-15	Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers NKTX +15.70% NKTX +5.68% GlobeNewswire
Apr-09	Nkarta to Participate in Needham Virtual Healthcare Conference NKTX GlobeNewswire
Mar-25	Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights NKTX GlobeNewswire
Feb-27	Nkarta to Participate in March Investor Conferences NKTX GlobeNewswire
Dec-02	Nkarta to Participate in Evercore Healthcare Conference NKTX GlobeNewswire
Nov-10	Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights NKTX GlobeNewswire
Oct-30	Nkarta to Participate in November Investor Conferences NKTX GlobeNewswire
Oct-22	Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting NKTX -7.95% GlobeNewswire
Sep-02	Nkarta to Participate in a September Investor Conference NKTX GlobeNewswire
Aug-12	Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights NKTX +12.76% NKTX GlobeNewswire
Jul-23	Nkarta to Participate in the H.C. Wainwright "HCW@Home" Series NKTX +7.21% GlobeNewswire
Jun-06	Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus NKTX GlobeNewswire
May-14	Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights NKTX -8.02% NKTX GlobeNewswire